TrialNCT04736173Phase 2Active not recruiting
Study Evaluating Effectiveness and Safety of Zimberelimab and Domvanalimab in Lung Cancer
Study sponsor: Arcus Biosciences, Inc. · RCUS
Compare the available registry edits below. Primary completion is the date data collection ends for the main study measures; it does not tell you when results will be published.
Primary completion2027-05Estimated
Enrollment · participants169Actual
Source updated2026-08-31Last update listed in the registry record
Version history
Changes to this trial
Pro unlocks the full available history and CSV export. View Pro features
No recorded changes are available for this view and time period. Our history may be incomplete; this does not establish that the trial stayed unchanged.